NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31

Natera, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026

$399.42+5.98 (+1.52%)

Close on Oct 19, 2026

Market cap: $57.23B
P/E (TTM): –
Dividend yield: –

Natera, Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31
Revenue	2,306	1,697	1,083	820	625	391	302	258	210	213	190	159	55
Cost of Revenue	–	–	–	–	–	–	–	158	136	134	113	78	37
Gross Profit	–	–	–	–	–	–	–	100	74	78	78	81	18
Research & Development	624	404	321	316	264	100	51	51	50	42	28	17	12
Selling, General & Admin	1,177	841	618	589	511	304	206	155	155	136	110	63	32
Advertising Expenses	11	2.30	1.10	1.80	2.20	0.60	0.20	0.20	0.50	0.40	1.10	1.10	0.40
Total Costs & Expenses	2,616	1,919	1,529	1,361	1,094	607	419	372	345	314	250	159	80
Operating Income	-310	-222	-446	-541	-468	-216	-116	-115	-135	-101	-60	0.67	-25
Interest Expense	4.07	11	13	9.32	8.31	15	11	10	4.21	0.53	3.51	4.22	1.87
Other Non-Operating Income	–	–	–	–	–	–	–	–	–	–	-7.90	-1.72	0.10
Merger & Restructuring Charges	–	–	–	–	0.40	–	–	–	–	–	–	–	–
Asset Impairment Charges	–	–	–	–	0	–	1.67	1.54	0.58	2.14	1.56	–	–
Gain (Loss) on Investments	–	–	–	-0.91	0.05	0.11	0.02	-0.04	-0.06	0.19	–	–	–
Gain (Loss) on Sale of Assets	–	–	–	–	–	–	14	0.01	-0.01	–	0.00	-0.01	–
Pretax Income	-268	-190	-435	-547	-471	-230	-123	-128	-137	-100	-70	-5.15	–
Income Tax Expense	-60	0.70	0.27	0.98	0.62	0.10	2.00	0.32	0.45	0.14	–	0.02	–
Net Income incl. Noncontrolling Interests	-208	-190	-435	-548	-472	-230	-125	-128	-138	-100	-70	–	–
Net Income	-208	-190	-435	-548	-472	-230	-125	-128	-138	-100	-70	-5.15	-37
Net Income to Common	–	–	–	-548	-472	-230	-125	-128	-138	-100	-70	–	–
EPS (Basic)(per share)	-1.52	-1.53	-3.78	-5.57	-5.21	-2.84	-1.79	-2.22	-2.58	-1.95	-2.68	-1.07	-9.66
EPS (Diluted)(per share)	-1.52	-1.53	-3.78	-5.57	-5.21	-2.84	-1.79	-2.22	-2.59	-1.95	-2.68	-1.07	-9.66
Shares Outstanding (Basic, Weighted)(shares)	137	125	115	98	91	81	70	58	53	52	26	4.80	3.84
Shares Outstanding (Diluted, Weighted)(shares)	137	125	115	98	91	81	70	58	54	52	26	4.80	3.84
EBITDA	-268	-191	-422	-524	-457	-208	-109	-107	-128	-95	-54	5.81	-23
Provision for Credit Losses	–	–	–	–	0.16	–	–	–	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: –
Operating margin: -10.7%
Net margin: -7.1%
Return on equity, FY2025: -14.3%

Financial strength

Current ratio: 3.00
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 197.3%

Valuation

P/E ratio: –
Price to sales: 21.14
Price to book: 31.42
Dividend yield: –